Pavenstädt, Hermann

Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial

Zarbock, A., Kellum, J. A., Schmidt, C., Van Aken, H., Wempe, C., Pavenstädt, H., Boanta, A., Gerß, J., & Meersch, M. (2016) · JAMA

Acute Kidney Injury ResearchRespiratory Support and Mechanisms

Cited by 1,143

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

Walz, G., Budde, K., Mannaa, M., Nürnberger, J., Wanner, C., Sommerer, C., Kunzendorf, U., Banas, B., Hörl, W. H., Obermüller, N., et al. (2010) · New England Journal of Medicine

Genetic and Kidney Cyst DiseasesTuberous Sclerosis Complex Research

Cited by 587

Temporal-spatial expression and novel biochemical properties of the memory-related protein KIBRA

Johannsen, S., Duning, K., Pavenstädt, H., Kremerskothen, J., & Boeckers, T. M. (2008) · Neuroscience

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 91

Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice

Stepan, J., Heinz, D. E., Dethloff, F., Wiechmann, S., Martinelli, S., Hafner, K., Ebert, T., Junglas, E., Häusl, A. S., Pöhlmann, M. L., et al. (2024) · Science Signaling

Neuroscience and Neuropharmacology ResearchHippo pathway signaling and YAP/TAZ

Cited by 20

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients

Jehn, U., Schütte-Nütgen, K., Henke, U., Pavenstädt, H., Suwelack, B., & Reuter, S. (2021) · Scientific Reports

Renal Transplantation Outcomes and TreatmentsChronic Kidney Disease and Diabetes

Cited by 6